Loading…

A lower eicosapentaenoic acid/arachidonic acid ratio is associated with in-hospital fatal arrhythmic events in patients with acute myocardial infarction: a J-MINUET substudy

The ratio of serum eicosapentaenoic acid (EPA) to arachidonic acid (AA) is significantly associated with long-term clinical outcomes in patients with acute myocardial infarction (AMI). However, it has not been conclusively demonstrated that higher serum EPA/AA ratio fares better clinical outcomes in...

Full description

Saved in:
Bibliographic Details
Published in:Heart and vessels 2018-05, Vol.33 (5), p.481-488
Main Authors: Hashimoto, Takuya, Ako, Junya, Nakao, Koichi, Ozaki, Yukio, Kimura, Kazuo, Noguchi, Teruo, Yasuda, Satoshi, Suwa, Satoru, Fujimoto, Kazuteru, Nakama, Yasuharu, Morita, Takashi, Shimizu, Wataru, Saito, Yoshihiko, Hirohata, Atsushi, Morita, Yasuhiro, Inoue, Teruo, Okamura, Atsunori, Uematsu, Masaaki, Hirata, Kazuhito, Tanabe, Kengo, Shibata, Yoshisato, Owa, Mafumi, Tsujita, Kenichi, Funayama, Hiroshi, Kokubu, Nobuaki, Kozuma, Ken, Uemura, Shirou, Toubaru, Tetsuya, Saku, Keijirou, Ohshima, Shigeru, Nakai, Michikazu, Nishimura, Kunihiro, Miyamoto, Yoshihiro, Ogawa, Hisao, Ishihara, Masaharu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The ratio of serum eicosapentaenoic acid (EPA) to arachidonic acid (AA) is significantly associated with long-term clinical outcomes in patients with acute myocardial infarction (AMI). However, it has not been conclusively demonstrated that higher serum EPA/AA ratio fares better clinical outcomes in the early phase of AMI. The Japanese registry of acute Myocardial INfarction diagnosed by Universal dEfiniTion (J-MINUET) is a prospective multicenter registry conducted in 28 Japanese medical institutions between July 2012 and March 2014. We enrolled 3,283 consecutive AMI patients who were admitted to participating institutions within 48 h of symptom onset. A serum EPA/AA ratio was available for 629 of these patients. The endpoints were in-hospital mortality and major adverse cardiac events (MACE), defined as a composite of all cause death, cardiac failure, ventricular tachycardia (VT) and/or ventricular fibrillation (VF) and bleeding during hospitalization. Although similar rates of in-hospital mortality, cardiac failure, bleeding, and MACE were found in the lower serum EPA/AA group and higher serum EPA/AA group, the incidence of VT/VF during hospitalization was significantly higher in the low ratio group ( p  = 0.008). Receiver operating characteristic curve analysis showed that an EPA/AA ratio
ISSN:0910-8327
1615-2573
DOI:10.1007/s00380-017-1084-2